网织红细胞计数在监测胸部肿瘤患者化疗后骨髓抑制状态的探讨

王梅; 陈爽

您当前的位置：

首页 >

文章列表页 >

网织红细胞计数在监测胸部肿瘤患者化疗后骨髓抑制状态的探讨

更新时间：2024-01-17

- 网织红细胞计数在监测胸部肿瘤患者化疗后骨髓抑制状态的探讨
- The value of immature reticulocyte count in monitoring the suppression of bone marrow function in patients with chest tumor during postoperative chemotherapy
- 重庆医科大学学报 2006年第4期页码：585-586
- 作者机构：
  
  1. 重庆医科大学附属第一医院检验科
  2. 重庆市防疫站
- 作者简介：
- 基金信息：
- DOI：
  中图分类号： R730.4;R730.5
- 纸质出版日期：2006，
扫描看全文
[1]王梅,陈爽.网织红细胞计数在监测胸部肿瘤患者化疗后骨髓抑制状态的探讨[J].重庆医科大学学报,2006(04):585-586+596.

WANG Mei, et al. The value of immature reticulocyte count in monitoring the suppression of bone marrow function in patients with chest tumor during postoperative chemotherapy[J]. Journal of Chongqing Medical University, 2006,(4):585-586.
[1]王梅,陈爽.网织红细胞计数在监测胸部肿瘤患者化疗后骨髓抑制状态的探讨[J].重庆医科大学学报,2006(04):585-586+596. DOI：

WANG Mei, et al. The value of immature reticulocyte count in monitoring the suppression of bone marrow function in patients with chest tumor during postoperative chemotherapy[J]. Journal of Chongqing Medical University, 2006,(4):585-586. DOI：

摘要

目的:探讨网织红细胞计数监测胸部肿瘤患者化疗后骨髓抑制状态的临床价值。方法:41例胸部肿瘤患者（其中肺癌22例

食管癌19例）

根治术后均接受紫杉醇联合顺铂的化疗方案。采用sysmexSE-9000全自动血细胞分析仪动态观察化疗过程中外周血网织红细胞和白细胞数。结果:与化疗前相比

化疗后第7天高荧光强度网织红细胞（HFR）和中荧光强度网织红细胞（MFR）之和（HFR+MFR）显著下降（P<0.01）

而白细胞下降没有显著性意义（P>0.05）。化疗后第14天上两项指标均降低（P<0.01）结论:网织红细胞计数下降较白细胞计数下降早

可作为早期评价肿瘤病人化疗过程中骨髓造血状态的敏感指标。

Abstract

Objective: To investigate the clinical value of immature reticulocyte count in early monitoring the suppression of bone marrow function in patients with chest tumor during postoperative chemotherapy.Methods:Forty-one patients with chest tumor(22 with lung cancer?19 with esophagus cancer) received chemotherapy after radical operation.Several indexes including reticulocyte count and white blood cell(WBC) were detected with sysmex SE-9000 automated analyzer during the procedure of postoperative chemotherapy.Results:Compared with the value before chemotherapy

HFR+MFR was significantly lower than that at 7 days after chemotherapy(P<0.01)

indicating that function of marrow was suppressed.Meanwhile the WBC count kept unchanged.After two weeks

the count of HFR+MFR and WBC reduced significantly.Conclusion:The change of reticulocyte count is earlier than that of WBC

with demonstnates reticulocyte count may act as a sensitive indicator in monitoring the suppression of bone marrow function in patients with chest tumor during chemotherapy.

关键词

网织红细胞骨髓抑制化疗胸部肿瘤

Keywords

Reticulocyte countThe suppression of bone marrow functionchemotherapyChest tumor

references

浏览量

125

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

维迪西妥单抗和术后化疗用于治疗人表皮生长因子受体2阳性的局限性尿路上皮癌患者的临床疗效分析

渐进性肌肉放松训练对肺癌化疗患者情绪与应对方式的影响

替比夫定预防和治疗化疗后的乙肝病毒再激活临床疗效分析

乳腺癌化疗相关HBV再激活的研究进展

抗癌药物敏感试验（MTT法）在胃肠道恶性肿瘤化疗中的临床应用